An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared with Nicorette® lozenge 4 mg in healthy adults who use cigarettes
SM25-01
Phase 1 other active
Quick answer
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared with Nicorette® lozenge 4 mg in healthy adults who use cigarettes for Nicotine use is a Phase 1 program (other) at Swedish Orphan Biovitrum International AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Swedish Orphan Biovitrum International AB
- Indication
- Nicotine use
- Phase
- Phase 1
- Modality
- other
- Status
- active